Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1241.10
-4.40 (-0.35%) USFDA completes audit at Dr. Reddy's Lab’s Srikakulam plant
Date: 29-01-2020US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy's Laboratories manufacturing plant at Srikakulam, Andhra Pradesh (CTO VI). The audit completed on January 28, 2020. After the audit, the company has been issued Form 483 with 5 observations.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.